Renalytix Plc (RENXF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
At close: Feb 11, 2026
Renalytix Revenue
In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M with 30.43% growth. Renalytix had revenue of $522.00K in the quarter ending September 30, 2024, with 13.73% growth.
Revenue
3.00M
Revenue Growth
+35.07%
P/S Ratio
8.04
Revenue / Employee
65.22K
Employees
46
Market Cap
24.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.00M | 700.00K | 30.43% |
| Jun 30, 2024 | 2.30M | -1.10M | -32.41% |
| Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
| Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
| Jun 30, 2021 | 1.49M | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |